Nrc Health (NRC) Liabilities and Shareholders Equity (2010 - 2026)

Nrc Health has disclosed Liabilities and Shareholders Equity across 17 years of filings, most recently posting $136.2 million for Q2 2026.

• In Q2 2026, Liabilities and Shareholders Equity fell 3.7% year-over-year to $136.2 million; the TTM figure through Jun 2026 stood at $541.3 million (changed 0.08% YoY), while the FY2025 annual figure was $134.9 million, up 1.76% from the prior year.
• Liabilities and Shareholders Equity came in at $136.2 million for Q2 2026 at Nrc Health, up from $134.6 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $153.2 million in Q1 2022 to a low of $119.1 million in Q2 2024.
• Average Liabilities and Shareholders Equity over 5 years is $132.6 million, with a median of $134.4 million recorded in 2023.
• Year-over-year, Liabilities and Shareholders Equity retreated 17.19% in 2022 and grew 18.71% in 2025.
• Over 5 years, Liabilities and Shareholders Equity stood at $130.5 million in 2022, then declined by 6.15% to $122.4 million in 2023, then grew by 8.25% to $132.5 million in 2024, then gained by 1.76% to $134.9 million in 2025, then gained by 0.94% to $136.2 million in 2026.
• Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $136.2 million in Q2 2026, $134.6 million in Q1 2026, and $134.9 million in Q4 2025.